CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, July 29th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...